<?xml version="1.0" encoding="UTF-8"?>
<ref id="bb0275">
 <label>54</label>
 <element-citation publication-type="journal" id="rf0265">
  <person-group person-group-type="author">
   <name>
    <surname>Domachowske</surname>
    <given-names>J.B.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>A.A.</given-names>
   </name>
   <name>
    <surname>Esser</surname>
    <given-names>M.T.</given-names>
   </name>
   <name>
    <surname>Jensen</surname>
    <given-names>K.</given-names>
   </name>
   <name>
    <surname>Takas</surname>
    <given-names>T.</given-names>
   </name>
   <name>
    <surname>Villafana</surname>
    <given-names>T.</given-names>
   </name>
  </person-group>
  <article-title>Safety, tolerability and pharmacokinetics of MEDI8897, an extended half-life single-dose respiratory syncytial virus prefusion F-targeting monoclonal antibody administered as a single dose to healthy preterm infants</article-title>
  <source>Pediatr Infect Dis J</source>
  <volume>37</volume>
  <issue>9</issue>
  <year>2018</year>
  <fpage>886</fpage>
  <lpage>892</lpage>
  <ext-link ext-link-type="uri" xlink:href="pmid:29373476" id="ir0350" xmlns:xlink="http://www.w3.org/1999/xlink">29373476</ext-link>
  <comment>PMCPMC6133204</comment>
  <pub-id pub-id-type="pmid">29373476</pub-id>
 </element-citation>
</ref>
